Invention Grant
![Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines](/docs/US/2018-06-26/US10004735B2/abs.jpg.600x600.jpg)
- Patent Title: Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines
-
Application No.: US15655270Application Date: 2017-07-20
-
Publication No.: US10004735B2Publication Date: 2018-06-26
- Inventor: Kimberly Elizabeth Fultz , Tam Minh Tran , Shuichan Xu , Weiming Xu
- Applicant: Signal Pharmaceuticals, LLC
- Applicant Address: US CA San Diego
- Assignee: Signal Pharmaceuticals, LLC
- Current Assignee: Signal Pharmaceuticals, LLC
- Current Assignee Address: US CA San Diego
- Agency: Jones Day
- Main IPC: A61K31/4985
- IPC: A61K31/4985 ; A61K31/704 ; A61K31/7048 ; A61K31/282 ; A61K31/337 ; A61K31/519 ; A61K31/517 ; A61K31/44 ; A61K31/4184 ; A61K38/14 ; A61K31/69 ; A61K31/501
![Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines](/abs-image/US/2018/06/26/US10004735B2/abs.jpg.150x150.jpg)
Abstract:
Provided herein are methods for treating or preventing a cancer, comprising administering an effective amount of a TOR kinase inhibitor and an effective amount a second active agent to a patient having a cancer.
Public/Granted literature
Information query
IPC分类:
